OUR RECOMMENDATIONS
1. HPV must be understood, and responded to, as a threat to the health of all sexes and genders.
OUR RECOMMENDATIONS
2. GNV should be viewed from the perspective of its potential to eliminate high-risk, oncogenic HPV types, thereby accelerating the elimination of not only cervical cancer but also all the cancers caused by HPV.
OUR RECOMMENDATIONS
3. By 2028, global policymakers should have reviewed the issue of GNV with a view to recommending its implementation. WHO should make boys a primary target for HPV vaccination.
OUR RECOMMENDATIONS
4. By 2030, all countries currently without an HPV vaccination programme should have introduced HPV vaccination on a gender-neutral basis while countries currently with a girls-only programme should have transitioned to GNV.
OUR RECOMMENDATIONS
5. Health partnerships between countries with established GNV programmes and lower-income countries should be established along with capacity-building initiatives to support the wider implementation of GNV.
OUR RECOMMENDATIONS
6. A greater focus is needed on increasing vaccine uptake to at least 90% for all, a target most likely to be achieved through school-based vaccination programmes.
We have the means to protect everyone – whatever their sex or gender – from high-risk HPV infections and the cancers they cause. To achieve this, a more ambitious, ethical and equitable approach to HPV vaccination is needed at the global and national levels.
Global Action on Men’s Health, NOMAN is an Island: Race to End HPV and the supporters of this Call believe there should be a new global goal of gender-neutral HPV vaccination in every country by 2030